Alzheimer's disease biomarkers: correspondence between human studies and animal models

Sabbagh, Jonathan J., Kinney, Jefferson W., Cummings, Jeffrey L.·2013·Neurobiology of Disease
DOI 10.1016/j.nbd.2013.04.010

Cites (284)

Items 201–283 of 283

  1. Age-Dependent Impairment of Somatosensory Response in the Amyloid Precursor Protein 23 Transgenic Mouse Model of Alzheimer's Disease
    Thomas Mueggler, Diana Kindler, Martin Rausch, Matthias Staufenbiel, Markus Rudin · 2003 · Journal of Neuroscience
  2. Amyloid-β Peptide and Oligomers in the Brain and Cerebrospinal Fluid of Aged Canines
    Elizabeth Head, Viorela Pop, Floyd M. Sarsoza, Rakez Kayed, Tina L. Beckett, Christa M. Studzinski, Jennifer L. Tomic, Charles G. Glabe, Michael Paul Murphy · 2010 · Journal of Alzheimer s Disease
  3. Reduced medial temporal lobe N -acetylaspartate in cognitively impaired but nondemented patients
    Linda L. Chao, Norbert W. Schuff, Joel H. Kramer, Antao Du, Arístides Andrés Capizzano, Joseph O’Neill, Owen M. Wolkowitz, William J. Jagust, H. C. Chui, Bruce L. Miller et al. · 2005 · Neurology
  4. Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease
    M. Thambisetty, A. Hye, C. Foy, E. Daly, A. Glover, A. Cooper, A. Simmons, D. Murphy, S. Lovestone · 2008 · Journal of Neurology
  5. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications
    Jonathan J. Sabbagh, Jefferson W. Kinney, Jeffrey L. Cummings · 2012 · Neurobiology of Aging
  6. Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers
    Thomas Jude Montine, Elaine R. Peskind, Joseph F. Quinn, Angela M. Wilson, Kathleen S. Montine, Douglas R Galasko · 2010 · NeuroMolecular Medicine
  7. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease
    Ángela González‐Martínez, Belén Rosado, Pedro Pesini, M. L. Suarez, German Santamarina, S. García‐Belenguer, Ainara Villegas, Inmaculada Monleón, Manuel Sarasa · 2011 · Experimental Gerontology
  8. Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic Mice
    Shuangqing Chen, Peijun Wang, Gao-Jun Ten, Wei Zhan, Minghua Li, Fengchao Zang · 2009 · Dementia and Geriatric Cognitive Disorders
  9. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease
    Joseph F. Quinn, Kathleen S. Montine, Milar M. Moore, Jason D. Morrow, Jeffrey Alan Kaye, Thomas Jude Montine · 2004 · Journal of Alzheimer s Disease
  10. PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition
    Géraldine Poisnel, Martine Dhilly, Olivier Moustié, Jérôme Delamare, Ahmed Abbas, Denis Guilloteau, Louisa Barré · 2012 · Neurobiology of Aging
  11. A multicenter 1 H-MRS study of the medial temporal lobe in AD and MCI
    Frank Jessen, O. Gür, Wolfgang Block, Gabriele Ende, Lutz Frölich, Thilo Hammen, Jens Wiltfang, Thomas Kucinski, Holger Jahn, Reinhard Heun et al. · 2009 · Neurology
  12. Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group
    Mikio Shoji, Etsuro Matsubara, Tetsuro Murakami, Yasuhiro Manabe, Koji Abe, Mitsuyasu Kanai, Masaki Ikeda, Yasushi Tomidokoro, Masami Shizuka, Masao Watanabe et al. · 2002 · Neurobiology of Aging
  13. 4 2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography
    John Tiernan O'Brien, Sean J. Colloby, Sanjeet Pakrasi, Elaine King Perry, Sally L. Pimlott, D. Wyper, Ian Grant McKeith, E. D. Williams · 2006 · Journal of Neurology Neurosurgery & Psychiatry
  14. Senile plaques do not induce susceptibility effects in T2*‐weighted MR microscopic images
    Marc Dhénain, Nicolas Privat, Charles J. Duyckaerts, Russell E. Jacobs · 2002 · NMR in Biomedicine
  15. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid1–42
    Terrence Town, Martina Vendrame, Anant Patel, Daniel Poetter, Anthony DelleDonne, Takashi Mori, Robert Smeed, Fiona Crawford, Thomas Klein, Jun Tan et al. · 2002 · Journal of Neuroimmunology
  16. Impaired Eyeblink Conditioning and Decreased Hippocampal Volume in PDAPP V717F Mice
    Craig Weiss, Palamadai N. Venkatasubramanian, Allison Aguado, John Power, B.C. Tom, Luna J. Li, K.S. Chen, John F. Disterhoft, Alice M. Wyrwicz · 2002 · Neurobiology of Disease
  17. Alzheimer's disease amyloid β-clipping enzyme (APP secretase): Identification, purification, and characterization of the enzyme
    Kazuhiko Tagawa, Tatsuhide Kunishita, Kei Maruyama, Kazuaki Yoshikawa, Eiki Kominami, Takahide Tsuchiya, Koichi Suzuki, Takeshi Tabira, Hideo Sugita, Shoichi Ishiura · 1991 · Biochemical and Biophysical Research Communications
  18. Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound
    Cook, Jacquelynn J., Wildsmith, Kristin R., Gilberto, David B., Holahan, Marie A., Kinney, Gene G., Mathers, Parker D., Michener, Maria S., Price, Eric A., Shearman, Mark S., Simon, Adam J. et al. · 2010 · The Journal of Neuroscience
  19. In vivo measurement of plaque burden in a mouse model of Alzheimer's disease
    Arijitt Borthakur, Tamar Gur, Andrew J. Wheaton, Matthew T. Corbo, John Q. Trojanowski, Virginia M.‐Y. Lee, Ravinder D Reddy · 2006 · Journal of Magnetic Resonance Imaging
  20. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies
    Sean J. Colloby, Michael Firbank, Sanjeet Pakrasi, Jim J. Lloyd, Ian Driver, Ian Grant McKeith, E. D. Williams, John Tiernan O'Brien · 2008 · International Psychogeriatrics
  21. Plasma F2A Isoprostane Levels in Alzheimer’s and Parkinson’s Disease
    Michael C. Irizarry, Y. Yao, Bradley T. Hyman, John H. Growdon, Domenico Praticò · 2007 · Neurodegenerative Diseases
  22. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice
    Einar M. Sigurdsson, Youssef Zaim Wadghiri, Lisa Mosconi, Jeffrey A. Blind, Elin Knudsen, Ayodeji A. Asuni, Henrieta Scholtzova, Wai Hon Tsui, Yongsheng Li, Martin J. Sadowski et al. · 2007 · Neurobiology of Aging
  23. Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI
    Ji‐Eun Kim, In-Young Choi, Mary Lou Michaelis, Phil Lee · 2011 · NeuroImage
  24. Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy
    Nicolau Beckmann, Christelle Gérard, Dorothée Abramowski, Catherine Cannet, Matthias Staufenbiel · 2011 · Journal of Neuroscience
  25. The neurobiology of isoprostanes and Alzheimer's disease
    Domenico Praticò · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  26. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510)
    Yang, Dewen, Xie, Zhiyong, Stephenson, Diane, Morton, Daniel, Hicks, Carol D., Brown, Tracy M., Sriram, Renuka, O'Neill, Sharon, Raunig, David, Bocan, Thomas · 2011 · NeuroImage
  27. Cortical Activation During Cholinesterase-Inhibitor Treatment in Alzheimer Disease: Preliminary Findings From a Pharmaco-fMRI Study
    Tilo T. J. Kircher · 2005 · American Journal of Geriatric Psychiatry
  28. Targeting Vascular Amyloid in Arterioles of Alzheimer Disease Transgenic Mice With Amyloid β Protein Antibody-Coated Nanoparticles
    Joseph F. Poduslo, Kristi L. Hultman, Geoffry L. Curran, Gregory M. Preboske, Ryan Chamberlain, Małgorzata Marjańska, Michael Garwood, Clifford R. Jack, Thomas M. Wengenack · 2011 · Journal of Neuropathology & Experimental Neurology
  29. Tracking Alzheimerʼs disease in transgenic mice using fluorodeoxyglucose autoradiography
    Reiman, Eric M., Uecker, Anne, Gonzalez-Lima, F, Minear, Deanna, Chen, Kewei, Callaway, Narriman Lee, Berndt, Jason D., Games, Dora · 2000 · NeuroReport
  30. BACE1 as a Potential Biomarker for Alzheimer's Disease
    Boris Decourt, Marwan Noel Sabbagh · 2011 · Journal of Alzheimer s Disease
  31. Intraneuronal amyloid β and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease
    Van Broeck, Bianca, Vanhoutte, Greet, Pirici, Daniel, Van Dam, Debby, Wils, Hans, Cuijt, Ivy, Vennekens, Krist’l, Zabielski, Monika, Michalik, Andrej, Theuns, Jessie et al. · 2008 · Neurobiology of Aging
  32. Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease
    Harald Juergen Hampel, Désirée Schoen, Markus Schwarz, H. U. Kötter, Claudia Schneider, Trey Sunderland, Ruth A. Dukoff, Jim Levy, Frank Padberg, Susanne Stübner et al. · 1997 · Neuroscience Letters
  33. Anti-inflammatory treatment in AD mice protects against neuronal pathology
    Ji‐Kyung Choi, Bruce G. Jenkins, Isabel Carreras, Şükrü Kaymakçalan, Kerry Cormier, Neil W. Kowall, Alpaslan Dedeoglu · 2009 · Experimental Neurology
  34. Alteration of cortical EEG in mice carrying mutated human APP transgene
    Jun Wang, Sami Ikonen, Kestutis Gurevicius, Thomas van Groen, Heikki Tanila · 2002 · Brain Research
  35. The Merits of FDDNP-PET Imaging in Alzheimer's Disease
    Jonghan Shin, Vladimir Kepe, Jorge R. Barrio, Gary W. Small · 2011 · Journal of Alzheimer s Disease
  36. Serum biomarkers for Alzheimer's disease: Proteomic discovery
    Dwight C. German, Prem Gurnani, Animesh Nandi, Harold R. Garner, Wayne G. Fisher, Ramon R. Diaz-Arrastia, Padraig E. O’Suilleabhain, Kevin P. Rosenblatt · 2007 · Biomedicine & Pharmacotherapy
  37. Interference from Heterophilic Antibodies in Amyloid-β Oligomer ELISAs
    Dag Sehlin, Sofia Söllvander, Staffan Paulie, RoseMarie Brundin, Martin Ingelsson, Lars Lannfelt, Frida Ekholm Pettersson, Hillevi Englund · 2010 · Journal of Alzheimer s Disease
  38. Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: comprehensive phenotyping of vascular and tissular parameters by MRI
    Weidensteiner, Claudia, Metzger, Friedrich, Bohrmann, Andreas Bruns Bernd, Kuennecke, Basil, von Kienlin, Markus · 2009 · Magnetic Resonance in Medicine
  39. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease
    Blaise B. Frederick, In Kyoon Lyoo, Andrew Satlin, Kyung Heup Ahn, M. Justin Kim, Deborah A Yurgelun-Todd, Bruce M. Cohen, Perry Franklin Renshaw · 2004 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  40. Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer's disease
    Mengchao Cui, Masahiro Ono, Hiroyuki Kimura, Hidekazu Kawashima, Bo Li Liu, Hideo Saji · 2010 · Nuclear Medicine and Biology
  41. In vivo SPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease
    Joachim Mazère, Caroline Prunier, Olivier Barret, M. Guyot, Caroline Hommet, Denis Guilloteau, J. F. Dartigues, Sophie Auriacombe, Colette Fabrigoule, Michèle Allard A · 2007 · NeuroImage
  42. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease
    Albertine Dubois, Anne‐Sophie Hérard, Benoı̂t Delatour, Philippe Hantraye, Gilles Bonvento, Marc Dhénain, Thierry Delzescaux · 2010 · NeuroImage
  43. Meningeal cells can communicate with astrocytes by calcium signaling
    Bernice Grafstein, Shujun Liu, Maria Luisa Cotrina, Steven A. Goldman, Maiken Nedergaard · 2000 · Annals of Neurology
  44. Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid
    Hillevi Englund, Malin Degerman Gunnarsson, RoseMarie Brundin, Marie Hedlund, Lena Kilander, Lars Lannfelt, Frida Ekholm Pettersson · 2009 · Neurodegenerative Diseases
  45. Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration
    Massimiliano Marco Corsi Romanelli, Federico Licastro, Elisa Porcellini, Giada Dogliotti, Emanuela Galliera, John L. Lamont, Paul J. Innocenzi, Stephen P. Fitzgerald · 2011 · Biogerontology
  46. Spatial Distribution of Glucose Hypometabolism Induced by Intracerebroventricular Streptozotocin in Monkeys
    Jae‐Hyeok Heo, Sang‐Rae Lee, Soon‐Tae Lee, Kyoungmin Lee, Jin-Hwan Oh, Dong Pyo Jang, Kyu-Tae Chang, Zang‐Hee Cho · 2011 · Journal of Alzheimer s Disease
  47. Cerebrospinal Fluid Aβ and Tau Level Fluctuation in an Older Clinical Cohort
    Abhay Moghekar · 2012 · Archives of Neurology
  48. The Role of Peripheral Benzodiazepine Receptors (PBRs) in CNS Pathophysiology
    Sen-yang Lang · 2002 · Current Medicinal Chemistry
  49. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS☆
    Dong‐Cheol Woo, Sung‐Ho Lee, Do‐Wan Lee, Sang-Young Kim, Goo‐Young Kim, Hyangshuk Rhim, Chi‐Bong Choi, Hwi‐Yool Kim, Chang‐Uk Lee, Bo‐Young Choe · 2010 · Behavioural Brain Research
  50. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
    Jiong Shi, George L. Perry, Marc S. Berridge, Gjumrakch M. Aliev, S. Siedlak, Mark A. Smith, Joseph C. LaManna, Robert Paul Friedland · 2002 · PubMed
  51. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease
    Michael Fraser Shanks, William Jonathan McGeown, Katrina Forbes‐McKay, Gordon D. Waiter, Mario G. Ries, Annalena Venneri · 2007 · Magnetic Resonance Imaging
  52. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1‐6 upregulates IL‐10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease
    Hong‐Duck Kim, Kazuki Tahara, J. Adam Maxwell, Robert Lalonde, Tatsuya Fukuiwa, Kohtaro Fujihashi, Kent R. Van Kampen, Fan-Kun Kong, De-chu Christopher Tang, Ken‐ichiro Fukuchi · 2007 · The Journal of Gene Medicine
  53. Decreased Activation Along the Dorsal Visual Pathway After a 3-Month Treatment With Galantamine in Mild Alzheimer Disease
    Arun L.W. Bokde, Michaela Karmann, Stefan Johannes Teipel, Christine Born, Martin Lieb, Maximilian Ferdinand Reiser, Hans‐Jürgen Möller, Harald Juergen Hampel · 2009 · Journal of Clinical Psychopharmacology
  54. [F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-Aβ antibody treatment
    Edmond Teng, Vladimir Kepe, Sally Ann Frautschy, Jie Liu, Nagichettiar Satyamurthy, Fusheng Yang, Pingping Chen, Graham B. Cole, Mychica R. Jones, Sung‐Cheng Huang et al. · 2011 · Neurobiology of Disease
  55. Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP
    Akihiro Noda, Yoshihiro Murakami, Shingo Nishiyama, Dai Fukumoto, Sosuke Miyoshi, Hideo Tsukada, Shintaro Nishimura · 2008 · Synapse
  56. MR Microimaging of amyloid plaques in Alzheimer’s disease transgenic mice
    Thomas M. Wengenack, Clifford R. Jack, Michael Garwood, Joseph F. Poduslo · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
  57. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer?s disease
    Roberto Ceravolo, Duccio Volterrani, G. Gambaccini, Carlo Alfonso Rossi, Chiara Logi, Gianpiero Manca, Caterina Berti, Giuliano Mariani, Luigi Murri, Ubaldo Bonuccelli · 2003 · Neurological Sciences
  58. Biomarkers for Microglial Activation in Alzheimer′s Disease
    Ronald Lautner, Niklas Mattsson, Michael Schöll, Kristin Augutis, Kaj Blennow, Bob Olsson, Henrik Zetterberg · 2011 · International Journal of Alzheimer s Disease
  59. Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α
    Miki Kozuki, Tomoko Kurata, Kazunori Miyazaki, Nobutoshi Morimoto, Yasuyuki Ohta, Yoshio Ikeda, Koji Abe · 2011 · Brain Research
  60. Visualization of Brain Amyloid and Microglial Activation in Mouse Models of Alzheimers Disease
    Higuchi, Makoto · 2009 · Current Alzheimer Research
  61. Muscarinic acetylcholine receptor status in Alzheimer’s disease assessed using (R, R) 123I-QNB SPECT
    Sanjeet Pakrasi, Sean J. Colloby, Michael Firbank, Elaine King Perry, D. Wyper, J. Owens, Ian Grant McKeith, E. D. Williams, John Tiernan O'Brien · 2007 · Journal of Neurology
  62. Reduction of Aβ Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for Aβ Production Inhibitors
    Mohammed El Mouedden, Marc Vandermeeren, Theo Frans Meert, Marc H. Mercken · 2006 · Current Pharmaceutical Design
  63. Effects of Image Resolution on Autoradiographic Measurements of Posterior Cingulate Activity in PDAPP Mice: Implications for Functional Brain Imaging Studies of Transgenic Mouse Models of Alzheimer's Disease
    Jonathan E. Valla, Kewei Chen, Jason D. Berndt, Francisco Gonzalez-Lima, Simon R. Cherry, Dora Games, Eric M. Reiman · 2002 · NeuroImage
  64. Dynamics of Aβ42 Reduction in Plasma, CSF and Brain of Rats Treated with the γ-Secretase Modulator, GSM-10h
    Julie Hawkins, David C. Harrison, Sharlin F. Ahmed, Robert P. Davis, Trevor D. Chapman, Ian Marshall, Beverley B. Smith, Tania L. Mead, Andrew D. Medhurst, Ged M.P. Giblin et al. · 2011 · Neurodegenerative Diseases
  65. Nicotinic 123I-5IA-85380 Single Photon Emission Computed Tomography as a Predictor of Cognitive Progression in Alzheimer's Disease and Dementia With Lewy Bodies
    Sean J. Colloby, Elaine King Perry, Sanjeet Pakrasi, Sally L. Pimlott, David J. Wyper, Ian Grant McKeith, E. D. Williams, John Tiernan O'Brien · 2009 · American Journal of Geriatric Psychiatry
  66. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease
    Andrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, Malin Degerman-Gunnarsson, Lars Lannfelt, Thomas A. Bayer · 2009 · Neurobiology of Aging
  67. Altered brain response for semantic knowledge in Alzheimer's disease
    Christina E. Wierenga, Nikki H. Stricker, Ashley McCauley, Alan N. Simmons, Amy J. Jak, Yu‐Ling Chang, Daniel A. Nation, Katherine J. Bangen, David P. Salmon, Mark William Bondi · 2010 · Neuropsychologia
  68. Preclinical 1 H-Mrs Neurochemical Profiling in Neurological And Psychiatric Disorders
    Moonnoh R. Lee, Aleksandar Đenić, David J. Hinton, Prasanna K. Mishra, Doo‐Sup Choi, Istvan Pirko, Moses Rodriguez, Slobodan I Macura · 2012 · Bioanalysis
  69. Pharmacokinetics and Amyloid Plaque Targeting Ability of a Novel Peptide-Based Magnetic Resonance Contrast Agent in Wild-Type and Alzheimer’s Disease Transgenic Mice
    Karunya K. Kandimalla, Thomas M. Wengenack, Geoffry L. Curran, Emily J. Gilles, Joseph F. Poduslo · 2007 · Journal of Pharmacology and Experimental Therapeutics
  70. Simultaneous Arterial Spin Labeling Cerebral Blood Flow and Morphological Assessments for Detection of Alzheimer’s Disease
    Tuvshinjargal Dashjamts, Takashi Yoshiura, Akio Hiwatashi, Koji Yamashita, Akira Monji, Yasumasa Ohyagi, Hironori Kamano, Toshiro Kawashima, Jun‐ichi Kira, Hiroshi Honda · 2011 · Academic Radiology
  71. Non-invasive characterization of β-amyloid1-40 vasoactivity by functional magnetic resonance imaging in mice
    Feng Luo, Terese R. Seifert, Rohinton P. Edalji, Ralf W. Loebbert, Vincent P. Hradil, John E. Harlan, Martin U. Schmidt, Volker Nimmrich, B. F. Cox, Gerard B. Fox · 2008 · Neuroscience
  72. Reduction of hippocampal N‐acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons
    Wei Xu, Yanqiang Zhan, Wei Huang, Xuxia Wang, Sumin Zhang, Hao Chuan Lei · 2010 · Journal of Neuroscience Research
  73. Nonprogressive transgene-related callosal and hippocampal changes in PDAPP mice
    Jon Valla, Lonnie E. Schneider, Francisco Gonzalez-Lima, Eric M. Reiman · 2006 · Neuroreport
  74. Development of a specific ELISA to measure BACE1 levels in human tissues
    Amanda Gonzales, Boris Decourt, Aaron W. Walker, Rachel M. Condjella, Hikmet Feyza Nural, Marwan Noel Sabbagh · 2011 · Journal of Neuroscience Methods
  75. Responders to ChEI Treatment of Alzheimers Disease Show Restitution of Normal Regional Cortical Activation
    Annalena Venneri, William Jonathan McGeown, Michael Fraser Shanks · 2009 · Current Alzheimer Research
  76. CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy
    Norbert Žilka, Miroslava Korenova, Branislav Kováčech, Khalid Iqbal, Michal Novák · 2010 · Acta Neuropathologica
  77. Alzheimer’s Disease Clinical Trials: Changing the Paradigm
    Jeffrey L. Cummings · 2011 · Current Psychiatry Reports
  78. Proteomic analysis of plasma from a Tau transgenic mouse
    Yoon‐Ha Kim, E. C. Lee, Seung‐Ah Park, Nam‐Hee Kim, Chan‐Wha Kim · 2012 · International Journal of Developmental Neuroscience
  79. Correlation of Behavior Changes and BOLD Signal in Alzheimer-like Rat Model
    Zhenghui Hu, Xiaochuan Wang, Liyun Li, Maili Liu, Rong Liu, Zhi-qun Ling, Qing Tian, Xiaowei Tang, Yi-gen Wu, Jian‐Zhi Wang · 2004 · Acta Biochimica et Biophysica Sinica
  80. Assessment of Non-Viral Amyloid-β DNA Vaccines on Amyloid-β Reduction and Safety in Rhesus Monkeys
    Yoriko Tokita, Kentaro Kaji, Jun Lu, Yoshio Okura, Kuniko Kohyama, Yoh Matsumoto · 2011 · Journal of Alzheimer s Disease
  81. Aβ(42) induced MRI changes in aged rabbit brain resembles AD brain
    Balenahalli Narasingappa Ramesh, Keshav Prakash Raichurkar, N.M. Shamasundar, TS Sathyanarayana Rao, K. S. Jagannatha Rao · 2011 · Neurochemistry International
  82. Untitled work
    2000 · 10.1002/1531-8249(200012)48:6
  83. Untitled work
    2000 · 10.1002/1531-8249(200011)48:5